| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.44 | 0.002 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |